期刊文献+

病理性瘢痕组织中微血管密度的测定及与survivin mRNA的表达关系 被引量:1

Measurement of microvessel density (MVD)and its relationship with expression of survivin mRNA in pathologic scar
原文传递
导出
摘要 目的测定病理性瘢痕组织中CD105标记的微血管密度(microvesiel density,MVD)和survivin mRNA的表达,探讨病理性瘢痕组织中癌基因在血管形成中的作用。方法采用多相寡核苷酸探针原位杂交技术和免疫组织化学染色技术(SP法),分别检测survivin mRNA、CD105蛋白在40例病理性瘢痕、20例非病理性瘢痕和20例正常皮肤组织中的表达,并计数CD105标记的MVD。结果CD105-MVD、survivinmRNA在病理性瘢痕较非病理性瘢痕和正常皮肤的表达差异皆具有统计学意义(P〈0.05)。病理性瘢痕组中survivin mRNA表达与CD105-MVD表达有相关性(P〈0.05)。结论病理性瘢痕组织中,凋亡抑制基因survivin表达上调可能参与了其血管形成过程。 Objective To study the microvessel density (MVD) marked by CD105 and expression of survivin gene in pathologic scar, and to investigate the function of oncogenes in tumorigenic process and abnormal scarring. Methods In situ hybridization and immunohistochemical methods (SP technique) were used to detect survivin mRNA, CD105- MVD in 40 pathologic scar cases, 20 normotrophic scar ca ses, and 20 normal skin cases, respectively. The relationship between the expression of survivin mRNA and CD105- MVD in 40 pathologic scar cases were analyzed. Results Compared with normotrophic scar and normal skin cases, the expression of survivin mRNA, CD105- MVD were significant difference in pathologic scar cases (P〈0.05). In pathologic scar tissue, the expression of survivin had significant correlation with MVD marked by CD105 (P〈0. 05). Conclusion survivin is up regulated in pathologic scar, which may contribute to the vascular formation.
出处 《中华医学美学美容杂志》 2009年第4期264-266,共3页 Chinese Journal of Medical Aesthetics and Cosmetology
关键词 病理性瘢痕 SURVIVIN mRNA CD105 微血管密度 Pathologic scar Survivin mRNA CD105 Microvesiel density
  • 相关文献

参考文献11

  • 1Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis a new significant and independent prognostic factor in early-stage breast carcinoma. J Natl Cancer Inst, 1992, 84(24): 1875-1887.
  • 2Kato J, Kuwabara Y, Mitani M, et al. Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer, 2001, 95(2):92-95.
  • 3张一鸣,樊东力.病理性瘢痕血管生成的研究进展[J].中华整形外科杂志,2008,24(3):246-249. 被引量:1
  • 4Gougos A, Letarte M. Identification of a human endothelial cell antigen with monoelonal antibody 44G4 produced against a pre-B leukemic cell line. J Immunol, 1988, 141 (6): 1926- 1933.
  • 5李小静,孟刚.瘢痕微血管构筑的研究进展[J].中国临床康复,2002,6(4):480-481. 被引量:9
  • 6李小静,孟刚,宁金龙,张林.免疫组化法对不同类型瘢痕微血管的定量研究[J].实用美容整形外科杂志,2000,11(4):207-209. 被引量:6
  • 7Ambrosini G, Adida C, Ahieri DC. A novel anti apoptosis gene, survivin, expressd in cancer and lymphoma. Nat Med, 1997,3(8) :917-921.
  • 8Shin S, Sung BJ, Cho YS, et al. An anti-apoptoric protein human survivin is a direct inhibitor of caspase-3 and-7. Biochemistry, 2001,40(4) :1117-1123.
  • 9O'Connor DS, Schechner JS, Adida C, et al. Control of apotosis during angiogenesis by survivin expression in endothelial cells. Am J Pathol, 2000,156(2):393-398.
  • 10Mesri M, Morales-Ruiz M, Ackermann EJ, et al. Suppression of vascular endothelial growth factor-mediate endothelial cell protection by survivin targeting. Am J Pathol, 2001, 158 (5) : 1757- 1765.

二级参考文献59

共引文献35

同被引文献8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部